ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 954,48
1,85%
DAX
18 518,03
-0,44%
Brent Oil
83,235
-1,31%
Bitcoin
64 991,43
0,22%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioPlus Acquisition Corporation (BIOS)

  7. BioPlus Acquisition Corporation (BIOS) Actualités

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BIOS
DateHeureSourceTitreSymboleSociété
15/03/201912h00GlobeNewswire Inc.Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to MergeNASDAQ:BIOSBioPlus Acquisition Corporation
14/03/201903h11GlobeNewswire Inc.BioScrip Reschedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
25/02/201923h28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BIOSBioPlus Acquisition Corporation
25/02/201920h00GlobeNewswire Inc.BioScrip Schedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
15/02/201912h21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
03/01/201915h00GlobeNewswire Inc.BioScrip to Present at the 37th Annual J.P. Morgan Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
26/11/201822h30GlobeNewswire Inc.BioScrip to Host Analyst and Investor DayNASDAQ:BIOSBioPlus Acquisition Corporation
20/11/201815h00GlobeNewswire Inc.BioScrip to Present at the Bank of America Merrill Lynch 2018 Leveraged Finance ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
09/11/201822h22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BIOSBioPlus Acquisition Corporation
06/11/201814h46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
06/11/201814h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
06/11/201814h00GlobeNewswire Inc.BioScrip Reports Third Quarter 2018 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
01/11/201813h00GlobeNewswire Inc.BioScrip Comments on Implementation of Medicare Home Infusion Transition BenefitNASDAQ:BIOSBioPlus Acquisition Corporation
31/10/201822h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BIOSBioPlus Acquisition Corporation
31/10/201819h03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BIOSBioPlus Acquisition Corporation
25/10/201815h00GlobeNewswire Inc.BioScrip to Present at the 2018 Stephens NY Investment ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
24/10/201815h00GlobeNewswire Inc.BioScrip Schedules Release of Third Quarter 2018 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
22/10/201822h30GlobeNewswire Inc.BioScrip Appoints John McMahon as Chief Accounting OfficerNASDAQ:BIOSBioPlus Acquisition Corporation
05/09/201815h00GlobeNewswire Inc.BioScrip to Participate in Upcoming Investor ConferencesNASDAQ:BIOSBioPlus Acquisition Corporation
07/08/201814h00GlobeNewswire Inc.BioScrip Reports Second Quarter 2018 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
30/07/201814h30GlobeNewswire Inc.BioScrip Appoints Leslie McIntosh as Chief Human Resources OfficerNASDAQ:BIOSBioPlus Acquisition Corporation
23/07/201822h30GlobeNewswire Inc.BioScrip to Present at the 38th Annual Canaccord Genuity Growth ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
18/07/201822h30GlobeNewswire Inc.BioScrip Schedules Release of Second Quarter 2018 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
10/07/201814h30GlobeNewswire Inc.BioScrip Appoints Richard Denness as Chief Commercial OfficerNASDAQ:BIOSBioPlus Acquisition Corporation
10/05/201814h30GlobeNewswire Inc.BioScrip Reports First Quarter 2018 Financial ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
26/04/201822h30GlobeNewswire Inc.BioScrip Schedules Release of First Quarter 2018 Financial Results and Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
04/04/201813h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
26/03/201812h30GlobeNewswire Inc.BioScrip Timely Files Annual Form 10-K, Concludes Accounting Review and Provides Update on Immaterial Financial Statement Cor...NASDAQ:BIOSBioPlus Acquisition Corporation
26/03/201812h10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSBioPlus Acquisition Corporation
15/03/201822h30Business WireBioScrip Provides Update on Annual Form 10-K Filing StatusNASDAQ:BIOSBioPlus Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:BIOS

Dernières Valeurs Consultées

USOTC
TSCDY
Tesco (PK)
LSE
EDG2
Is Em Esg Acc
BOV
FSPM11
F3 Fundshares Portfolio ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés